Corporate News

MyHealthChecked PLC, the consumer home-testing healthcare company, announces its unaudited half-year report for the six months ended 30 June 2025.

Financial highlights

• Revenue of £0.5m (H1 2024: £0.9m; FY 2024: £3.6m) with wellness portfolio up c60% from H1 2024
• Adjusted EBITDA loss £1,230,000 (H1 2024: £1,199,000; FY 2024: £1,927,000)
• Cash balances of £5.06m (H1 2024: £6.05m; FY 2024: £5.47m)

Commercial and operational highlights

• The Company signed a partnership agreement with Patients Know Best ("PKB") to enable customers using at-home blood and DNA tests from MHC to access their laboratory test results via the NHS App
• MHC became the exclusive supplier of PocDoc into Boots, which was added to the boots.com range in April 2025 and launched in over 830 stores
• Signed agreement with Boots for the supply of a range of lateral flow self-tests and laboratory tests under the Boots' Own Brand (“OB”) label
• End-customer purchases of wellness tests performed well– 45% volume increase year-on-year
• Phlebotomy kits registered in the UK and EU and will be launched at retail at the earliest opportunity

Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said:
“As a Board we believe in the positive long-term growth potential for our wellness product range, but acknowledge that the category is still in its infancy and that awareness amongst potential end-users is currently limited.

“As an organisation with deep retail product knowledge, we have built a number of partnerships to support our retail engagement in the home-testing market. In particular, with Boots we are working with a trusted established retail organisation, with both digital reach and a bricks and mortar footprint, and we believe this is key to unlocking revenue potential in the UK market. With several promotional campaigns being launched by Boots in the coming months we expect to see demand increase as the range beds in, and increased product visibility as more shelf space is dedicated to the range in store. This, along with our other commercial partnerships, gives us confidence that we will continue to deliver year-on-year growth in end-user sales for our Wellness portfolio.”

 

MyHealthChecked PLC		www.myhealthcheckedplc.com
Adam Reynolds, Chairman Penny McCormick, Chief Executive Officer		via Walbrook PR
SPARK Advisory Partners Limited (NOMAD)		Tel: +44 (0)20 3368 3550
Neil Baldwin / Jade Bayat
Dowgate Capital Limited (Broker)		Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
Paul McManus / Alice Woodings		Mob: +44(0)7980 541 893 / +44(0)7407 804 654

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests are made available through MHC online and through retail partners in-store and online.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare and proactive wellness in the growing at home testing kit market, with a focus on accessibility at the right price, led by UK-based experts.